Minneapolis, MN, June 06, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW), an emerging biomedical device company focused on animal health, today announced a strategic collaboration with Commonwealth, the syndicated ownership group behind 2023 Kentucky Derby winner Mage, and 2022 Dubai World Cup Champion Country Grammer. The partnership centers on the clinical use and promotion of SPRYNG® with OsteoCushion® Technology, PetVivo’s cutting-edge intra-articular device designed to su ...

MIAMI, FL, May 29, 2025 (GLOBE NEWSWIRE) -- Digital Landia, LLC (“Digital Landia”), owner of Agentic.Pet, an autonomous pet artificial intelligence ecosystem, in cooperation with PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) and its wholly owned subsidiary PetVivo Animal Health, Inc. (collectively referred to herein as "PetVivo"), today announces the availability of a minimum viable product (MVP) of its revolutionary self-learning, multi-agent pet care platform that was officially launched on May 23, ...

MINNEAPOLIS, May 22, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) and its wholly-owned subsidiary PetVivo Animal Health, Inc. (collectively referred to herein as the "Company" or “PetVivo”) an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for animals, and PiezoBioMembrane, Inc (“PiezoBio”)., a pioneer in biodegradable piezoelectric materials intended for implantable applications, today announced a transform ...

MINNEAPOLIS, April 16, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) ("PetVivo"), an emerging biomedical device company focused on the commercialization of innovative medical devices and other therapeutics for equine and companion animals, announced today it has entered into a definitive distribution agreement with Eq Especialidades (“Eq Especialidades”). Eq Especialidades will inventory, market and promote PetVivo’s veterinary medical device, Spryng™ with OsteoCushion™ techn ...

MINNEAPOLIS, March 31, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) and its wholly-owned subsidiary PetVivo Animal Health, Inc. (collectively "PetVivo" or the "Company") an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for horses, dogs and other companion animals announced today that the Company has recently entered into a Subscription Agreement to receive Five Million Dollars ($5,000,000) of equity financing in exchan ...

Core Insights - PetVivo Holdings, Inc. has formed a strategic alliance with Digital Landia Corp. to integrate innovative AI technology into its veterinary products, creating a global pet care ecosystem focused on animal health [1][5] Partnership Structure and Strategic Benefits - PetVivo will invest $150,000 in restricted common stock for a 2% equity stake in Digital Landia, becoming the Platinum Sponsor of the Pet AI community [2] - The partnership includes economic benefits from 3 million Digital Landia tokens, with PetVivo's products being promoted when the AI detects joint-related afflictions in pets [2] Product Overview - SPRYNG® with OsteoCushion® Technology is an injectable veterinary medical device that aids in managing joint pain by restoring proper joint mechanics [3] - PrecisePRP® is a first-in-class, off-the-shelf platelet-rich plasma product designed for easy use by veterinarians, providing a consistent dose of platelets without the need for blood draws [4] Technology and Market Opportunity - Digital Landia's Pet AI platform utilizes self-learning algorithms to analyze animal behavior, achieving 97% accuracy in interpreting animal communication [1][5] - The partnership targets a significant market, with 66% of U.S. households owning pets, initially engaging 123 million American pet owners and expanding internationally [6] Revenue Model and Customer Engagement - The Pet AI platform offers a freemium model and a subscription tier, allowing for tailored learning and improved accuracy through user data [7] - PetVivo will collaborate with veterinarians to deploy AI agents that provide discounts on PetVivo products, enhancing customer loyalty [8] Company Overview - PetVivo Holdings, Inc. focuses on the commercialization of innovative medical devices for companion animals, leveraging human therapies for efficient treatment [9] - The company has a robust pipeline of products and holds twenty-one patents protecting its biomaterials and methods of use [10]

MINNEAPOLIS, Feb. 19, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets announced today it will be exhibiting at the Western Veterinary Conference to be held March 2nd to March 5th, 2025 at the Mandalay Bay Convention Center in Las Vegas, Nevada. PetVivo intends to exhibit its innovative product, SPRYNG® with OsteoCushion® Technology, an intra-articular i ...

MINNEAPOLIS, MN, US, Feb. 14, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW), a leading biomedical company delivering innovative therapeutics and medical devices for equines and companion animals, reported results for its fiscal third quarter ended December 31, 2024. All comparisons are to the same year-ago period unless otherwise noted. The company will hold a conference call today at 3:00 p.m. Eastern time to discuss the results for the period (see dial-in information below) ...

U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Mark One ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission File No. 001-40715 PetVivo Holdings, Inc. (Name of small business issuer in its charter) Nevada 99-0363559 (State or other jurisdiction of ...

MINNEAPOLIS, MN, Feb. 14, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW), a leader in innovative veterinary medical solutions, has entered into an Exclusive License and Supply Agreement with VetStem, Inc. to commercialize VetStem’s innovative allogeneic orthobiologic products, PrecisePRP® canine and PrecisePRP® equine. PrecisePRP® is a first-in-class off-the-shelf platelet-rich plasma (PRP) product designed for use by veterinarians. It is a leucoreduced, allogeneic, pooled, f ...